CG인바이츠

083790KOSDAQ자연과학 및 공학 연구개발업

48.4 / 100

Reference Date: 2026-06-10

Financial Score20.0 / 40

News Sentiment14.4 / 25

Momentum7.0 / 20

Disclosure7.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Plunged 26.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CGinBites operates in pharmaceutical R&D, AI healthcare solutions, and thermal patch manufacturing, with key projects including the approved drug 'Acell克斯' and ongoing clinical trials for cancer treatments. The company leads medical innovation through precision medicine platforms based on genomic analysis and AI-driven digital healthcare solutions. It also contributes to ecosystem expansion via venture investments and startup support.

Number of Employees

92people

Average Salary

60.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 62.704.0Point

PBR

0.55Industry Average 3.247.0Point

Half of industry avg (excellent)

ROE

-10.45Industry Average -32.093.5Point

Well below industry avg

Debt Ratio

13.45Industry Average 7.310.5Point

1.8x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲163.2% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -26.3% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 1Average Sentiment Score 57.5

Negative
CG인바이츠, 사옥 가압류에 배임성 손배소까지…신사업 성과는 언제
CG인바이츠의 사옥 가압류와 배임 소송 패소로 인해 재무적 어려움이 예상되며, 기업 이미지에 부정적 영향을 미칠 것으로 보입니다.
Neutral
K-디지털헬스케어 얼라이언스, 킥오프 미팅 개최…美 M&A 전략 공유
K-디지털헬스케어 얼라이언스의 첫 미팅 개최 소식은 관련 산업 동향에 대한 정보 제공에 초점을 맞추고 있어 CG인바이츠의 직접적인 영향은 제한적입니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 855Won52-week high 2,01552-week low 855

1-month return0.0Point

1m -26.92% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

8 totalPositive 0Neutral 7Negative 1

Negative소송등의판결ㆍ결정(일정금액이상의청구) (약정금)2026-06-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-18
Neutral분기보고서 (2026.03)2026-05-14